Today's Hours: 12:00pm - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    edited by J. Michael Dixon, Matthew D. Barber.
    Summary: "Breast Surgery meets the needs of surgeons in higher training and practising consultants for a contemporary and evidence-based account of this sub-specialty that is relevant to their general surgical practice. It is a practical reference source incorporating the most current information on recent developments, management issues and operative procedures. The text is thoroughly referenced and supported by evidence-based recommendations wherever possible, distinguishing between strong evidence to support a conclusion, and evidence suggesting that a recommendation can be reached on the balance of probabilities"--Publisher's description.

    Contents:
    Anatomy and physiology of the breast
    Assessment of patient, breast and common clinical presentations including image guided intervention
    Benign breast disease
    Breast pathology
    Epidemiology, Risk Factors, and Prevention Strategies
    Breast screening
    Breast-conserving surgery: the balance between good cosmesis and local control
    Oncoplastic Breast Conserving Surgery
    Mastectomy
    Management of the axilla
    Uncommon presentations of cancer affecting the breast
    The genetics of breast cancer, risk reducing surgery and prevention
    Breast reconstruction
    Treatment of ductal carcinoma in situ
    The role of adjuvant systemic therapy in patients with operable breast cancer
    Neoadjuvant therapy for breast cancer including surgical considerations
    Adjuvant radiotherapy for breast cancer
    Locally advanced breast cancer
    Metastatic breast cancer and palliative care
    Psychosocial issues in breast cancer
    Management of common breast emergencies and complications.
    Digital Access ClinicalKey 2019
  • Article
    Benda L, Haider M, Ambrosch F.
    Wien Klin Wochenschr. 1977 Dec 09;89(23):779-83.
    A multicentre study of cases of acute myocardial infarction was undertaken at 27 departments at teaching and non-teaching hospitals throughout Austria over a period of three years. Altogether 3397 patients were investigated. On classification of the patients according to the number of shock indicators, two comparable groups (B and C) of "mild" infarction with 0, 1 or 2 signs of shock were obtained. These low-risk groups comprised 728 patients. The mortality in group C ("mild" infarction, no streptokinase) was 17.3%, significantly higher (p less than 0.01) than the corresponding figure of 10.5% in group B ("mild" infarct, streptokinase therapy). The decrease in mortality by streptokinase therapy applied both to monitored patients as well as to those who were not monitored. Haemorrhage was a very rare complication, but somewhat more frequent in the streptokinase-treated cases, as expected. The incidence of complications such as stereocardia, asystole, and cardiac insufficiency, as well as the conversion of "mild" cases into a "severe" symptomatology was markedly reduced in the streptokinase-treated group.
    Digital Access Access Options